...Fund, undisclosed remainder from DNDi April 2014 PDE4NDP (PhosphoDiEsterase inhibitors for Neglected Parasitic Diseases) project Iota Pharmaceuticals Ltd....

...PROTHEVIH project to develop HIV vaccine VAC-3S, companion diagnostic test CO-3S and prognostic test DIAG-3S Iota Pharmaceuticals Ltd....

...to conduct human clinical trials. The partners will share "benefits and revenues" of shared IP. IOTA Pharmaceuticals Ltd....

...total budget of €3.6 million ($5.1 million) over four years. Further terms were not disclosed. IOTA Pharmaceuticals Ltd....

...of Amsterdam Corporate partners: Cubist Pharmaceuticals Inc. , General Electric Co. , AstraZeneca plc , Iota Pharmaceuticals Ltd....

...discovery partnerships with pharma companies. Further terms were not disclosed. Beactica AB , Uppsala, Sweden Iota Pharmaceuticals Ltd....

...at the VU University in Amsterdam by Iwan de Esch, Iota's head of drug discovery. Iota Pharmaceuticals Ltd....